Literature DB >> 2667210

Biopsy diagnosis and clinical outcome of persistent focal pulmonary lesions after marrow transplantation.

S W Crawford1, R C Hackman, J G Clark.   

Abstract

We reviewed the results of all percutaneous fine needle aspirations (FNA) and open lung biopsies (OLB) after bone marrow transplantation at our center (1984-1987) for the evaluation of focal lung lesions that developed or persisted despite antibiotic administration. We sought to determine the prevalence and types of infections, the yield of diagnostic procedures, and the clinical outcome of these focal lesions. Infection was documented in 78% (18/23) of all lesions and was fungal in each case. FNA detected fungal lung infection with a sensitivity of 67% (10/15) but had a negative predictive value of only 50% (5/10). Complications occurred in 15% of FNA. OLB without prior FNA was performed in 6 cases and demonstrated fungal infections in 5. Overall, seven of the 18 patients with localized invasive fungal lung disease recovered after antifungal therapy. This study demonstrates that focal lung lesions that develop or persist despite antibiotics after BMT are most often fungal. FNA may safely identify these localized infections in selected patients and with appropriate treatment recovery may be achieved.

Entities:  

Mesh:

Year:  1989        PMID: 2667210     DOI: 10.1097/00007890-198908000-00017

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  2 in total

1.  The diagnostic yield of CT-guided percutaneous lung biopsy in solid organ transplant recipients.

Authors:  Joe L Hsu; Ware G Kuschner; Jane Paik; Natalie Bower; Maria C Vazquez Guillamet; Nishita Kothary
Journal:  Clin Transplant       Date:  2012 Jul-Aug       Impact factor: 2.863

2.  Decline in the Use of Surgical Biopsy for Diagnosis of Pulmonary Disease in Hematopoietic Cell Transplantation Recipients in an Era of Improved Diagnostics and Empirical Therapy.

Authors:  Guang-Shing Cheng; Zach J Stednick; David K Madtes; Michael Boeckh; George B McDonald; Steven A Pergam
Journal:  Biol Blood Marrow Transplant       Date:  2016-08-31       Impact factor: 5.742

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.